Lactobacillus rhamnosus UALr-18 and Improved Disease Management

• The Gut Microbiome Advances Precision Medicine and Diagnostics for Inflammatory Bowel Diseases.

  • 2024-10-19
  • Review
  • International journal of molecular sciences 25(20)
  • • Walaa K Mousa
    • Aya Al Ali

  • PubMed: 39457040
  • DOI: 10.3390/ijms252011259

  2 Insights on

  • Improved Disease Management

  • Moderate evidence
  • Rigorous Journal

  This explosion of microbiome data inspired the development of next-generation therapeutics for treating IBD that depend on manipulating the gut microbiome by diet modulation or using live products as therapeutics.

  Effect

  Beneficial

  Effect size

  Small